Modeling the evolution of ETV6-RUNX1–induced B-cell precursor acute lymphoblastic leukemia in mice
-
- Louise van der Weyden
- Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom;
-
- George Giotopoulos
- Cambridge Institute for Medical Research, Addenbrooke's Hospital, Cambridge, United Kingdom;
-
- Alistair G. Rust
- Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom;
-
- Louise S. Matheson
- The Babraham Institute, Babraham Research Campus, Cambridge, United Kingdom;
-
- Frederik W. van Delft
- The Institute of Cancer Research, Section of Haemato-Oncology, Surrey, United Kingdom; and
-
- Jun Kong
- Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom;
-
- Anne E. Corcoran
- The Babraham Institute, Babraham Research Campus, Cambridge, United Kingdom;
-
- Mel F. Greaves
- The Institute of Cancer Research, Section of Haemato-Oncology, Surrey, United Kingdom; and
-
- Charles G. Mullighan
- St Jude Children's Research Hospital, Memphis, TN
-
- Brian J. Huntly
- Cambridge Institute for Medical Research, Addenbrooke's Hospital, Cambridge, United Kingdom;
-
- David J. Adams
- Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, United Kingdom;
説明
<jats:title>Abstract</jats:title><jats:p>The t(12;21) translocation that generates the ETV6-RUNX1 (TEL-AML1) fusion gene, is the most common chromosomal rearrangement in childhood cancer and is exclusively associated with B-cell precursor acute lymphoblastic leukemia (BCP-ALL). The translocation arises in utero and is necessary but insufficient for the development of leukemia. Single-nucleotide polymorphism array analysis of ETV6-RUNX1 patient samples has identified multiple additional genetic alterations; however, the role of these lesions in leukemogenesis remains undetermined. Moreover, murine models of ETV6-RUNX1 ALL that faithfully recapitulate the human disease are lacking. To identify novel genes that cooperate with ETV6-RUNX1 in leukemogenesis, we generated a mouse model that uses the endogenous Etv6 locus to coexpress the Etv6-RUNX1 fusion and Sleeping Beauty transposase. An insertional mutagenesis screen was performed by intercrossing these mice with those carrying a Sleeping Beauty transposon array. In contrast to previous models, a substantial proportion (20%) of the offspring developed BCP-ALL. Isolation of the transposon insertion sites identified genes known to be associated with BCP-ALL, including Ebf1 and Epor, in addition to other novel candidates. This is the first mouse model of ETV6-RUNX1 to develop BCP-ALL and provides important insight into the cooperating genetic alterations in ETV6-RUNX1 leukemia.</jats:p>
収録刊行物
-
- Blood
-
Blood 118 (4), 1041-1051, 2011-07-28
American Society of Hematology